Search results

A Medscape article entitled "Five-Day Course of Oral Antiviral Appears to Stop SARS-CoV-2 in Its Tracks" was recently published. Don't fall for the title. It's not that simple.

The 'Open Science Prize' is a collaboration between three of the biggest sources of science funding around. The intent is to inspire novel ways of making science accessible to aid in public health. The winner - an online tool that will change the course of how viral outbreaks are tracked - was announced this week. 

Sepsis occurs when the body’s response to infection goes into overdrive, leading to tissue damage, organ failure, and death. Sepsis has an overall mortality rate of between 20 and 50 percent, and kills more people than do HIV and breast cancer. It afflicts up to 500,000 people a year in the U.S. and millions more worldwide,.

New Vaccine May Give Norovirus the Heave Ho
By Josh Bloom, December 9, 2011

LigoCyte, a small biotech based in Montana has been working for years on a vaccine for norovirus (the so-called stomach flu, or cruise ship virus). And it looks like they may really have something.

Writing at Reason, Ron Bailey dissects some worrying trends and then highlights some insight on cancer which, I am proud to say, came from us.

Phase III trials put the efficacy of the two earliest COVID-19 vaccines in the mid-’90s, certainly more than we had hoped. The word on the media “street” has been that vaccinations result in fewer hospitalizations and no deaths. The CDC is now reporting on “breakthrough infections” since the beginning of the year. 

The recent reporting on Flint's water crisis by CNN's Christiane Amanpour has a tenuous grasp of the data and the reality. 

Several superficially plausible arguments against COVID-19 vaccination continue to pop up across the internet, usually phrased as leading questions. Are they as solid as they seem? A little investigation suggests they are mostly speculation.

Four stories: Phylogenetic analysis suggests that coronavirus arrived in the U.S. between late January and early February. The coronavirus has resulted in more than 1.2 million years of life lost (YLLs) in the U.S. The coronavirus isn't the only game in town. And some people who are most likely to be affected by coronavirus are also refusing to go to the hospital.

In the media, it's not uncommon to see the words "bacteria" and "virus" used interchangeably. However, they are far from the same thing. In response to a recent Post article that made this microbiological faux pas, we feel the need to clarify and explain the differences.

Fast or slow furniture? Asymptomatic infections are not confined to COVID-19. Plants can social distance? Tap water hesitancy

Hospital Compare, a CMS website, provides "star-ratings" to hospitals based on performance. It's dropping the safety measures from the star-rating scoring, but it's maintaining the information in another database. Does removing safety measures make the ratings less useful? The answer is, as is often the case, complicated.

I've seen some odd things in my career, but a November 7 report in Drug Industry Daily may be one of the craziest. Maybe "Looney Tunes" crazy.
The article reports on discussions being held between the FDA and representatives of PhRMA concerning the development and launching of badly needed new antibiotics to combat bacterial pneumonia.

Obesity is known to be a major risk factor for type 2 diabetes, as well as for the insulin resistance that's a hallmark of the disease. Mouse studies suggest that obesity results in the production of microRNAs by adipose tissue, which diminishes the ability of tissues to respond to insulin.

To cope with high pollen levels during vigorous exercise should an athlete pop a couple of antihistamines? There’s no definitive answer, but new research finds that 27 percent of genes activated after vigorous exercise become blunted in their responses during a three-hour recovery period, if exercisers had taken strong doses of antihistamines.

In 2012, the hepatitis C universe changed forever when Gilead's Sovaldi was approved. Finally, there was an excellent drug that could eliminate the infection almost all the time. But some strains of HCV are tougher than others to treat. But now, Gilead strikes again.

Gene drive technology is powerful and slightly frightening. But the coronavirus pandemic reminds us that we want to have multiple weapons in the public health arsenal, should we be confronted with another life-threatening microbe.

Not literally, but figuratively. Journalism's rule of thumb is true; bad news sells, and courtesy of a new study, we have some numbers to back that claim up. What we don’t know is why we prefer the negative over the positive.

Wastewater surveillance for highly pathogenic H5N1 flu virus is a vital tool in pandemic preparedness. To gauge the ongoing threat to humans from the virus, we need to up our game: Wastewater surveillance should be both expanded and more narrowly focused.

Is it too early to address what went wrong when the COVID vaccines were rolled out? This is not about the “first rough draft of history." Instead, it's a more dispassionate, high-altitude view that allows us to assess this public health moment through two different critical theory lenses: complex systems and scaling.

Type 1 diabetes occurs when the body fails to produce insulin. But Belgian researchers have come up with a potential solution: reprogramming pancreatic cells to produce insulin and respond to glucose. They announced this week that it's working well in models, with study in humans to hopefully take place.

As if hospitals aren't bad enough, a really dangerous bug called Clostridium difficile is all over the place. And this bug, more commonly known as (C. diff), is not so easy to kill. Researchers looked at what happens when you wash contaminated sheets. The expression "it call comes out in the wash" does not apply.

The U.S. has been adept at inventing The Next Big Thing, but sometimes stumbles when it comes to exploiting it. From cars to electronics, solar panels, and semiconductors, this pattern has been repeated. Biotechnology could be next unless we invest aggressively and regulate wisely.

As if there aren't enough ridiculous things to study – and worry about. A group in Great Britain thinks that sandwiches are causing the Earth to warm. Now there's a baloney sandwich – if there ever was one.

When the recent publication of a paper in Nature Methods claimed that using the CRISPR-Cas9 technique may cause unexpected mutations to occur, you might say that produced a collective gasp in the scientific community. But those who discovered CRISPR-Cas9 are not taking this criticism lightly – and they're fighting back.